IQVIA CORE-enabled Clinical Development at the Heart of Innovation and Launch Excellence

The case for integration and focus

White Paper

January 31, 2019
IQVIA CORE enabled Clinical Development at the Heart of Innovation and Launch Excellence
As the pharmaceutical industry turns to ever more sophisticated specialty treatments for highly defined, often very small patient populations, competition intensifies and payer tensions grow. The return on innovative launches has not kept pace with rising clinical development costs. This white paper presents the case for revolutionizing research and development, and outlines new approaches to make clinical trials more cost effective and focused from start to finish.